Related Experiment Video
Updated: Mar 22, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Unlocking the wasting enigma: Highlights from the 8th Cachexia Conference
Nicole Ebner1, Stephan von Haehling1
1University Medical Center Goettingen Department of Cardiology and Pneumology, Innovative Clinical Trials Goettingen Germany.
This article summarizes research on wasting disorders, including new therapeutic targets and markers for skeletal muscle wasting. Effective treatments are crucial for improving patient quality of life and survival.
Area of Science:
- Biomedical Research
- Clinical Medicine
- Pharmacology
Background:
- Wasting disorders, including cachexia, significantly impact patient quality of life and survival.
- There is an urgent need for effective treatments to manage skeletal muscle wasting.
- The 8th Cachexia Conference convened to discuss advancements in the field.
Purpose of the Study:
- To highlight pre-clinical and clinical studies on wasting disorders presented at the 8th Cachexia Conference.
- To present the biological and clinical significance of novel markers for wasting disorders.
- To discuss new therapeutic targets and drugs for treating skeletal muscle wasting.
Main Methods:
- Review of pre-clinical and clinical studies presented at the 8th Cachexia Conference.
- Analysis of presented data on biological and clinical markers.
- Evaluation of emerging therapeutic strategies and drug candidates.
Main Results:
- Presentation of interesting clinical trial results.
- Identification of several new therapeutic targets for cachexia and wasting disorders.
- Discussion of the significance of various markers in disease progression and treatment response.
Conclusions:
- Advancements in understanding wasting disorders were presented at the conference.
- New therapeutic targets and drugs show promise for skeletal muscle wasting treatment.
- Further research and development are essential to improve patient outcomes for wasting disorders.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Treatment Resistant Cancers
Treatment Resistent Cancers
Cardiomyopathy V: Interprofessional Care
Obesity
Heart Failure III: Clinical Manifestations
